Safety of heparinization for cerebral aneurysm coiling soon after external ventriculostomy drain placement
- PMID: 16284554
- DOI: 10.1227/01.neu.0000180814.95032.07
Safety of heparinization for cerebral aneurysm coiling soon after external ventriculostomy drain placement
Abstract
Objective: Our practice has been to heparinize patients for cerebral aneurysm coiling even after recent external ventriculostomy drain (EVD) placement. The current medical literature cites a 12.5% symptomatic hemorrhage rate with heparinization after recent EVD placement. We reviewed our experience to determine our level of safety with this practice.
Methods: A search of our prospectively collected computerized aneurysm database revealed that from February 1998 to February 2004, 356 aneurysms were coiled, of which 119 patients had had recent EVD placement before coiling. During the same time period, 251 subarachnoid hemorrhage patients underwent EVD placement without coiling or heparinization. We reviewed the head computed tomographic scan reports and medical records to determine the incidence of EVD-related hemorrhage in heparinized patients compared with nonheparinized patients.
Results: There was only 1 patient in the heparinized group who had a symptomatic EVD-related hemorrhage attributable to heparinization (0.8%) and 11 patients with asymptomatic EVD-related hemorrhage (9.2%). Among the nonheparinized patients, there were 3 patients who had symptomatic EVD-related hemorrhages (1.2%) and 22 patients with asymptomatic EVD-related hemorrhages (8.8%) (P = not significant for both symptomatic and asymptomatic EVD-related hemorrhages). The time interval between EVD placement and heparinization in the heparinized patient with symptomatic EVD-related hemorrhage was 0.5 day; the mean time interval in the heparinized patients with asymptomatic EVD-related hemorrhage was 0.8 day; and in the heparinized patients with no hemorrhage, it was 0.8 day. The peak activated prothrombin time of the heparinized patient with symptomatic EVD-related hemorrhage was >150 seconds, the mean peak activated prothrombin time of the heparinized patients with asymptomatic EVD-related hemorrhage was 73.1 seconds, and that of the heparinized patients with no hemorrhage was 90.3 seconds.
Conclusion: Heparinization for cerebral aneurysm coiling can be safely performed even after EVD placement within 24 hours, particularly if the activated prothrombin time is kept strictly controlled.
Similar articles
-
Hemorrhage rates of external ventricular drain (EVD), intracranial pressure gauge (ICP) or combined EVD and ICP gauge placement within 48 h of endovascular coil embolization of cerebral aneurysms.Clin Neurol Neurosurg. 2013 Aug;115(8):1399-402. doi: 10.1016/j.clineuro.2013.01.023. Epub 2013 Feb 18. Clin Neurol Neurosurg. 2013. PMID: 23428140
-
Hemorrhage Rate After External Ventricular Drain Placement in Subarachnoid Hemorrhage: Time to Heparin Administration.Neurocrit Care. 2017 Dec;27(3):350-355. doi: 10.1007/s12028-017-0417-4. Neurocrit Care. 2017. PMID: 28612132
-
Increased risk of Ventriculostomy-Associated hemorrhage in patients treated with antiplatelet agents for stent-assisted coiling of ruptured intracranial aneurysms.Br J Neurosurg. 2021 Jun;35(3):270-274. doi: 10.1080/02688697.2020.1787338. Epub 2020 Jul 9. Br J Neurosurg. 2021. PMID: 32643426
-
Ventriculostomy-related hemorrhage in patients on antiplatelet therapy for endovascular treatment of acutely ruptured intracranial aneurysms. A meta-analysis.Neurosurg Rev. 2020 Apr;43(2):397-406. doi: 10.1007/s10143-018-0999-0. Epub 2018 Jul 2. Neurosurg Rev. 2020. PMID: 29968172
-
Do iatrogenic factors bias the placement of external ventricular catheters?--a single institute experience and review of the literature.Neurol Med Chir (Tokyo). 2011;51(3):180-6. doi: 10.2176/nmc.51.180. Neurol Med Chir (Tokyo). 2011. PMID: 21441733 Review.
Cited by
-
Hemorrhagic Complications Associated with Ventriculostomy in Patients Undergoing Endovascular Treatment for Intracranial Aneurysms: A Single-Center Experience.Neurocrit Care. 2017 Aug;27(1):11-16. doi: 10.1007/s12028-016-0350-y. Neurocrit Care. 2017. PMID: 28000128
-
Venous Thromboembolism After Intraventricular Hemorrhage: Results From the CLEAR III Trial.Neurosurgery. 2019 Mar 1;84(3):709-716. doi: 10.1093/neuros/nyy189. Neurosurgery. 2019. PMID: 29788198 Free PMC article.
-
Bleeding and infection with external ventricular drainage: a systematic review in comparison with adjudicated adverse events in the ongoing Clot Lysis Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III (CLEAR-III IHV) trial.Neurosurgery. 2015 Mar;76(3):291-300; discussion 301. doi: 10.1227/NEU.0000000000000624. Neurosurgery. 2015. PMID: 25635887 Free PMC article. Clinical Trial.
-
Endovascular treatment of ruptured aneurysms and vasospasm.Curr Treat Options Neurol. 2007 Mar;9(2):146-57. doi: 10.1007/s11940-007-0040-3. Curr Treat Options Neurol. 2007. PMID: 17298775
-
Risk of hemorrhage in combined neuroform stenting and coil embolization of acutely ruptured intracranial aneurysms.Interv Neuroradiol. 2008 Dec 29;14(4):385-96. doi: 10.1177/159101990801400404. Epub 2009 Jan 5. Interv Neuroradiol. 2008. PMID: 20557738 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical